Precigen, Inc. (PGEN)
3.32
-0.05
(-1.48%)
USD |
NASDAQ |
Mar 06, 16:00
3.35
+0.03
(+0.90%)
After-Hours: 20:00
Precigen Cash from Investing (TTM) : -106.77M for Sept. 30, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Marker Therapeutics, Inc. | 0.00 |
| Amneal Pharmaceuticals, Inc. | -112.26M |
| Corcept Therapeutics, Inc. | 69.76M |
| CorMedix, Inc. | -308.43M |
| ADMA Biologics, Inc. | -21.89M |